Affective Prosody and Depression After Stroke: A Pilot Study. Villain, Marie; Cosin, Charlotte; Glize, Bertrand; Berthoz, Sylvie; Swendsen, Joel; Sibon, Igor; Mayo, Willy. Stroke. 2016; 2397-2400: p.2397-2400. doi:10.1161/STROKEAHA.116.013852Article
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. Parfrey, Patrick S.; Block, Geoffrey A.; Correa-Rotter, Ricardo; Drüeke, Tilman B.; Floege, Jürgen; Herzog, Charles A.; London, Gerard M.; Mahaffey, Kenneth W.; Moe, Sharon M.; Wheeler, David C.; Chertow, Glenn M.. Clinical journal of the American Society of Nephrology: CJASN. 2016; 539-546: p.539-546. doi:10.2215/CJN.06370615Article
[Epidemiology: Data from France and USA]. Dumas, Florence; Bougouin, Wulfran; Geri, Guillaume; Cariou, Alain. Presse Medicale (Paris, France: 1983). 2016; 45: p.832-838. doi:10.1016/j.lpm.2016.07.003Article
Reconsidering the Lack of Urea Toxicity in Dialysis Patients. Massy, Ziad A.; Pietrement, Christine; Touré, Fatouma. Seminars in Dialysis. 2016; 333-337: p.333-337. doi:10.1111/sdi.12515Article
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial. Chang, T. I.; Abdalla, S.; London, G. M.; Block, G. A.; Correa-Rotter, R.; Drüeke, T. B.; Floege, J.; Herzog, C. A.; Mahaffey, K. W.; Moe, S. M.; Parfrey, P. S.; Wheeler, D. C.; Dehmel, B.; Goodman, W. G.; Chertow, G. M.. Journal of Human Hypertension. 2016; 30: p.204-209. doi:10.1038/jhh.2015.56Article
Thyroid Cancer after Childhood Exposure to External Radiation: An Updated Pooled Analysis of 12 Studies. Veiga, Lene H. S.; Holmberg, Erik; Anderson, Harald; Pottern, Linda; Sadetzki, Siegal; Adams, M. Jacob; Sakata, Ritsu; Schneider, Arthur B.; Inskip, Peter; Bhatti, Parveen; Johansson, Robert; Neta, Gila; Shore, Roy; de Vathaire, Florent; Damber, Lena; Kleinerman, Ruth; Hawkins, Michael M.; Tucker, Margaret; Lundell, Marie; Lubin, Jay H.. Radiation Research. 2016; 473-484: p.473-484. doi:10.1667/RR14213.1Article
Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?. Ducreux, M.; Pignon, J. P.. Eur J Cancer. 2016; 178-179: p.178-179. doi:10.1016/j.ejca.2016.10.001 10.1016/j.ejca.2016.10.001. Epub 2016 Nov 10.Article
Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?. Wyatt, Christina M.; Drüeke, Tilman B.. Kidney International. 2016; 89: p.971-973. doi:10.1016/j.kint.2016.03.001Article
Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. McKeever, M. R.; Sio, T. T.; Gunn, G. B.; Holliday, E. B.; Blanchard, P.; Kies, M. S.; Weber, R. S.; Frank, S. J.. Chin Clin Oncol. 2016; 54: p.54. doi:10.21037/cco.2016.07.03 10.21037/cco.2016.07.03. Epub 2016 Aug 2.Article
Fibroblast growth factor receptor 4: the missing link between chronic kidney disease and FGF23-induced left ventricular hypertrophy?. Wyatt, Christina M.; Drüeke, Tilman B.. Kidney International. 2016; 89: p.7-9. doi:10.1016/j.kint.2015.11.012Article